Likelle makes life easier for MS patients

MS is the most common progressive central nervous system disease affecting the ability of young adults to exercise and function. It brings its own challenges to more than 7,000 Finnish people. In women, the disease is almost twice as common as among men and the onset of the disease is usually between the ages of […]

Biological medications require the right storage conditions

Do you want to increase your knowledge of new biological pharmaceuticals? I will give you some interesting details about these products. Numerous revolutionary pharmaceuticals have been developed in recent years for the treatment of many long-term illnesses. We are able to more successfully treat diseases, for which the options, for example in the early 2000s, […]

Duodopa and Apogo – more functional time for patients with Parkinson’s disease

Oral medication, deep stimulation of the brain and an intestinal levodopa-infusion (Duodopa) can be used to treat Parkinson’s disease. In addition, a recently introduced subcutaneous apomorphine infusion (Apogo) has recently become available on the market. Intestinal levodopa and subcutaneous apomorphine infusion have made it possible to significantly improve the quality of life and functional capacity […]

Likelle on the road – Dubai Arab Health 2017

Likelle was presenting products in Arab Health Exhibition 2017. In hot climate conditions securing pharmaceutical cold chain is always a concern. Increasing number of people using insulin means that also easy and carefree tools is needed to get out full power of treatment. Likelle focuses on to secure the last mile of pharmaceutical cold chain […]